Retrospective comparison of the efficacy of tonsillectomy with and without steroid-pulse therapy in IgA nephropathy patients

Internal Medicine

Volumn 51, Issue 11, 2012, Pages 1323-1328

  Nakagawa, Naoki ^a   Kabara, Maki ^a   Matsuki, Motoki ^a   Chinda, Junko ^a   Fujino, Takayuki ^a   Hirayama, Tomoya ^b   Takahara, Miki ^a   Harabuchi, Yasuaki ^a   Kikuchi, Kenjiro ^a   Hasebe, Naoyuki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Kitasaito Hospital   (Japan)

Author keywords

Clinical remission; IgA nephropathy; Methylprednisolone pulse; Tonsillectomy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; ANTIULCER AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG PULSE THERAPY; FEMALE; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION; MALE; MULTIPLE CYCLE TREATMENT; OBSERVATIONAL STUDY; PALATINE TONSILLECTOMY; PROTEINURIA; REMISSION; RETROSPECTIVE STUDY; STEROID THERAPY;

ADULT; COMBINED MODALITY THERAPY; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HEMATURIA; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PALATINE TONSIL; PROTEINURIA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TONSILLECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863085363     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7238     Document Type: Article

References (20)

1. Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am J Kidney Dis 29: 526-532, 1997.
2. Berthoux FC, Mohey H, Afiani A. Natural history of primary IgA nephropathy. Semin Nephrol 28: 4-9, 2008.
3. Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 15: 157-163, 2004.
4. Hiki Y, Odani H, Takahashi M, et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59: 1077-1085, 2001.
5. Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 38: 736-743, 2001.
6. Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Kitamura K. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: A controlled study. Clin J Am Soc Nephrol 3: 1301-1307, 2008.
7. Miura N, Imai H, Kikuchi S, et al. Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy. Clin Exp Nephrol 13: 460-466, 2009.
8. Appel GB, Waldman M. The IgA nephropathy treatment dilemma. Kidney Int 69: 1939-1944, 2006.
9. Locatelli F, Del Vecchio L, Pozzi C. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors. Nat Clin Pract Nephrol 2: 24-31, 2006.
10. Tomino Y, Sakai H. Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol 7: 93-97, 2003.
11. Asaba K, Tojo A, Onozato ML, et al. Long-term renal prognosis of IgA nephropathy with therapeutic trend shifts. Intern Med 48: 883-890, 2009.
12. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009.
13. Nicholls KM, Fairley KF, Dowling JP, Kincaid-Smith P. The clinical course of mesangial IgA associated nephropathy in adults. Q J Med 53: 227-250, 1984.
14. Bene MC, Hurault de Ligny B, Kessler M, Foliguet B, Faure GC. Tonsils in IgA nephropathy. Contrib Nephrol 104: 153-161, 1993.
15. Xie YS, Nishi S, Ueno M, et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int 63: 1861-1867, 2003.
16. Egido J, Blasco R, Lozano L, Sancho J, Garcia-Hoyo R. Immunological abnormalities in the tonsils of patients with IgA nephro-pathy: inversion in the ratio of IgA: IgG bearing lymphocytes and increased polymeric IgA synthesis. Clin Exp Immunol 57: 101-106, 1984.
17. Nozawa H, Takahara M, Yoshizaki T, Goto T, Bandoh N, Harabu-chi Y. Selective expansion of T cell receptor (TCR) V beta 6 in tonsillar and peripheral blood T cells and its induction by in vitro stimulation with Haemophilus parainfluenzae in patients with IgA nephropathy. Clin Exp Immunol 151: 25-33, 2008.
18. Goto T, Bandoh N, Yoshizaki T, et al. Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononu-clear cells stimulated with deoxycytidyl-deoxyguanosine oligode-oxynucleotides (CpG-ODN) in patients with IgA nephropathy. Clin Immunol 126: 260-269, 2008.
19. Suzuki Y, Tomino Y. Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: insights from animal models. Semin Nephrol 28: 66-77, 2008.
20. Wang Y, Chen JY, Wang YE, Chen Y, Wang L, Lv YM. A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant 26: 1923-1931, 2011.